John P. Butler Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John P. Butler.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John P. Butler. John P. Butler is a Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and a Director in Relypsa Inc ($RLYP) and a CEO & President in Akebia Therapeutics, Inc. ($AKBA) and a CEO and President in Akebia Therapeutics, Inc. ($AKBA) and a Director in Zynerba Pharmaceuticals, Inc. ($ZYNE).
Address: C/O RELYPSA, INC. 700 SAGINAW DRIVE REDWOOD CITY 94063 CA
Companies in which John P. Butler is an Insider
Akebia Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John P. Butler: CEO & President, CEO and President
Holdings: 1,152,153 shares
Current Value: $11,383,272
Latest Transaction: Apr 01 2021
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KERYX BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John P. Butler: Director
Holdings: 20,000 shares
Current Value: $107,000
Latest Transaction: Jun 20 2017
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Relypsa Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John P. Butler: Director
Holdings: 2,250 shares
Latest Transaction: Sep 02 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zynerba Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John P. Butler: Director
Holdings: 5,000 shares
Current Value: $92,350
Latest Transaction: Jun 11 2020
$ZYNE Market Capitalization: $186.92M
$ZYNE Previous Close: $18.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of John P. Butler
Sentiment: All, AKBA, KERX, RLYP, ZYNE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Sell | S | 3.40 | 4,109 | 13,971 | 1,152,153 | 1.2 M to 1.2 M (-0.36 %) |
| Mar 18 2021 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 39,520 | 0 | 1,156,262 | 1.1 M to 1.2 M (+3.54 %) |
| Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Option Exercise | A | 8.87 | 403,600 | 3,579,932 | 403,600 | |
| Mar 02 2020 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Grant | A | 0.00 | 237,400 | 0 | 1,026,632 | 789.2 K to 1 M (+30.08 %) |
| Nov 21 2019 | AKBA | Akebia Therapeutic ... | Butler John P. | CEO and President | Buy | P | 3.44 | 50,000 | 172,000 | 887,732 | 837.7 K to 887.7 K (+5.97 %) |
| Jun 13 2019 | ZYNE | Zynerba Pharmaceut ... | Butler John P. | Director | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 |